ProfileGDS4718 / 229202_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 49% 45% 57% 45% 49% 61% 58% 44% 43% 42% 45% 55% 49% 63% 55% 48% 50% 56% 70% 81% 46% 53% 46% 49% 49% 60% 46% 66% 58% 70% 51% 72% 48% 43% 61% 73% 55% 44% 46% 70% 45% 61% 75% 68% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.4442649
GSM549102patient 115, normal, homogenized [OPG study]5.2605145
GSM549104patient 119, normal, homogenized [OPG study]5.9451457
GSM549108patient 138, normal, homogenized [OPG study]5.2917545
GSM549119patient 077, normal, homogenized [OPG study]5.4636649
GSM549133patient 032, cancer, homogenized [OPG study]6.1488461
GSM549139patient 042, cancer, homogenized [OPG study]5.9828258
GSM549099patient 107, normal, homogenized [OPG study]5.2312644
GSM549109patient 139, normal, homogenized [OPG study]5.1840843
GSM549110patient 046, normal, homogenized [OPG study]5.0947842
GSM549114patient 063, normal, homogenized [OPG study]5.2004245
GSM549122patient 082, normal, homogenized [OPG study]5.7878855
GSM549134patient 033, cancer, homogenized [OPG study]5.4511749
GSM549136patient 036, cancer, homogenized [OPG study]6.3057363
GSM549140patient 044, cancer, homogenized [OPG study]5.7962355
GSM549111patient 047, normal, homogenized [OPG study]5.3844148
GSM549113patient 057, normal, homogenized [OPG study]5.4393450
GSM549132patient 031, cancer, homogenized [OPG study]5.8407956
GSM549137patient 038, cancer, homogenized [OPG study]6.9467770
GSM549142patient 047, cancer, homogenized [OPG study]7.6677181
GSM549100patient 110, normal, homogenized [OPG study]5.3332546
GSM549107patient 135, normal, homogenized [OPG study]5.6503553
GSM549115patient 068, normal, homogenized [OPG study]5.242746
GSM549116patient 072, normal, homogenized [OPG study]5.4194949
GSM549120patient 078, normal, homogenized [OPG study]5.4481849
GSM549131patient 030, cancer, homogenized [OPG study]6.1275460
GSM549118patient 074, normal, homogenized [OPG study]5.2733346
GSM549129patient 027, cancer, homogenized [OPG study]6.5820766
GSM549123patient 088, normal, homogenized [OPG study]5.9965858
GSM549124patient 006, cancer, homogenized [OPG study]6.8757970
GSM549126patient 015, cancer, homogenized [OPG study]5.5509951
GSM549128patient 025, cancer, homogenized [OPG study]7.1531772
GSM549103patient 117, normal, homogenized [OPG study]5.4406648
GSM549117patient 073, normal, homogenized [OPG study]5.0858543
GSM549138patient 041, cancer, homogenized [OPG study]6.2136261
GSM549141patient 045, cancer, homogenized [OPG study]7.2433273
GSM549130patient 028, cancer, homogenized [OPG study]5.7801155
GSM549101patient 111, normal, homogenized [OPG study]5.2315544
GSM549105patient 128, normal, homogenized [OPG study]5.3081646
GSM549106patient 134, normal, homogenized [OPG study]6.9292270
GSM549112patient 048, normal, homogenized [OPG study]5.2498845
GSM549125patient 011, cancer, homogenized [OPG study]6.2230761
GSM549127patient 024, cancer, homogenized [OPG study]7.3802475
GSM549135patient 035, cancer, homogenized [OPG study]6.7523168